Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials—II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials—II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma

Published:2004-06 Issue:5 Volume:15 Page:439-452
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Schwartz Jonathan D.,Beutler Andreas S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference67 articles.

1. Natural history of untreated nonsurgical hepatocellular carcinoma: rational for the design and evaluation of therapeutic trials;Llovet;Hepatology,1999

2. Chemotherapy in hepatocellular carcinoma;Okada;Hepatogastroenterology,1998

3. Chemoembolization of hepatocellular carcinoma: results of a metaanalysis;Geschwind;Am J Clin Oncol,2003

4. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival;Llovet;Hepatology,2003

5. Treatment of hepatocellular carcinoma: a systemic review of randomized controlled trials;Simonetti;Ann Oncol,1997

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microwave coagulation for liver metastases;Cochrane Database of Systematic Reviews;2024-03-27

2. Stomatin-like protein 2 promotes cell proliferation and survival under 5-Fluorouracil stress in hepatocellular carcinoma;Molecular Biology Reports;2024-01-28

3. Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study;Journal of Liver Cancer;2023-03-31

4. Electrocoagulation for liver metastases;Cochrane Database of Systematic Reviews;2021-01-28

5. Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway;Oxidative Medicine and Cellular Longevity;2020-01-20